These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 11747281

  • 1. Low basal androstenedione levels plus augmented 17alpha-hydroxyprogesterone and low dehydroepiandrosterone sulfate responses to adrenocorticotropic hormone stimulation in patients with adrenal incidentaloma.
    Ozgen AG, Bayraktar F, Yilmaz C.
    Endocr Pract; 2001; 7(6):448-53. PubMed ID: 11747281
    [Abstract] [Full Text] [Related]

  • 2. A comparison between the effects of low dose (1 microg) and standard dose (250 microg) ACTH stimulation tests on adrenal P450c17alpha enzyme activity in women with polycystic ovary syndrome.
    Colak R, Keleştimur F, Unlühizarci K, Bayram F, Sahin Y, Tutuş A.
    Eur J Endocrinol; 2002 Oct; 147(4):473-7. PubMed ID: 12370108
    [Abstract] [Full Text] [Related]

  • 3. Augmented 17 alpha-hydroxyprogesterone response to ACTH stimulation as evidence of decreased 21-hydroxylase activity in patients with incidentally discovered adrenal tumours ('incidentalomas').
    Seppel T, Schlaghecke R.
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):445-51. PubMed ID: 7955456
    [Abstract] [Full Text] [Related]

  • 4. Adrenal androgenic response to 2-hour ACTH stimulation test in women with PCOS.
    Erel CT, Senturk LM, Oral E, Colgar U, Ertungealp E.
    Gynecol Endocrinol; 1998 Aug; 12(4):223-9. PubMed ID: 9798131
    [Abstract] [Full Text] [Related]

  • 5. Twenty-four hour 17-hydroxyprogesterone response to adrenocorticotropine in adrenal incidentalomas: augmented response after adrenalectomy in two patients.
    Kamel N, Erdoğan MF, Tonyukuk V, Ilgin SD, Erdoğan G.
    Endocr J; 2002 Feb; 49(1):35-40. PubMed ID: 12008748
    [Abstract] [Full Text] [Related]

  • 6. Adrenal steroids in adrenomyeloneuropathy. Dehydroepiandrosterone sulfate, androstenedione and 17alpha-hydroxyprogesterone.
    Wichers-Rother M, Grigull A, Sokolowski P, Stoffel-Wagner B, Köhler W.
    J Neurol; 2005 Dec; 252(12):1525-9. PubMed ID: 16362829
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Elevated post-dexamethasone suppression cortisol concentrations correlate with hormonal alterations of the hypothalamo-pituitary adrenal axis in patients with adrenal incidentalomas.
    Tsagarakis S, Roboti C, Kokkoris P, Vasiliou V, Alevizaki C, Thalassinos N.
    Clin Endocrinol (Oxf); 1998 Aug; 49(2):165-71. PubMed ID: 9828902
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Increased risk of nephrolithiasis: an emerging issue in children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Chiarito M, Lattanzio C, D'Ascanio V, Capalbo D, Cavarzere P, Grandone A, Aiello F, Pepe G, Wasniewska M, Zoller T, Salerno M, Faienza MF.
    Endocrine; 2024 May; 84(2):727-734. PubMed ID: 38536547
    [Abstract] [Full Text] [Related]

  • 14. Apparent activities of 21-hydroxylase, 17alpha-hydroxylase and 17,20-lyase are impaired in adrenal incidentalomas.
    Sadoul JL, Kézachian B, Altare S, Hadjali Y, Canivet B.
    Eur J Endocrinol; 1999 Sep; 141(3):238-45. PubMed ID: 10474121
    [Abstract] [Full Text] [Related]

  • 15. 17-Hydroxyprogesterone responses to adrenocorticotropin in children with premature adrenarche.
    Granoff AB, Chasalow FI, Blethen SL.
    J Clin Endocrinol Metab; 1985 Mar; 60(3):409-15. PubMed ID: 2982895
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features.
    Rossi R, Tauchmanova L, Luciano A, Di Martino M, Battista C, Del Viscovo L, Nuzzo V, Lombardi G.
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1440-8. PubMed ID: 10770179
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. During a corticotropin-releasing hormone test in healthy subjects, administration of a beta-adrenergic antagonist induced secretion of cortisol and dehydroepiandrosterone sulfate and inhibited secretion of ACTH.
    Kizildere S, Glück T, Zietz B, Schölmerich J, Straub RH.
    Eur J Endocrinol; 2003 Jan; 148(1):45-53. PubMed ID: 12534357
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.